Your browser doesn't support javascript.
A European update on transcatheter aortic valve implantation (TAVI) in the COVID era.
Antony, Ishan; Mehari Abraha, Hyab; Hameed, Aamir; Conway, Claire.
  • Antony I; School of Medicine, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Mehari Abraha H; Department of Anatomy and Regenerative Medicine, Tissue Engineering Research Group (TERG), RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Hameed A; Department of Anatomy and Regenerative Medicine, Tissue Engineering Research Group (TERG), RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Conway C; Trinity Centre for Biomedical Engineering (TCBE), Trinity College Dublin, Dublin, Ireland.
J Anat ; 2022 Sep 24.
Article in English | MEDLINE | ID: covidwho-2238721
ABSTRACT
Minimally invasive approaches for aortic valve replacement are now at the forefront of pathological aortic valve treatment. New trials show comparability of these devices to existing therapies, not only in high-risk surgical cohorts but also in low-risk and intermediate-risk cohorts. This review provides vital clinical and anatomical background to aortic valvular disease treatment guidelines, while also providing an update on transcatheter aortic valve implantation (TAVI) devices in Europe, their interventional trials and associated complications.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Year: 2022 Document Type: Article Affiliation country: Joa.13740

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Year: 2022 Document Type: Article Affiliation country: Joa.13740